EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Teratoid Hepatoblastoma: Clinicopathologic Features and Outcomes

Brian T Hickner, Andres F Espinoza iD, Soo Jin Cho iD, Stephen Sarabia, Martin Urbicain, Ann Wang, Sanjeev A Vasudevan, Dolores H López-Terrada iD, Kalyani R Patel

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31903 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Brian T Hickner und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Surgery, Michael E. DeBakey Department of Surgery, Texas Children's Surgical Oncology Program and Liver Tumor Program, Dan L. D…. Hauptthemen laut MEDLINE: Hepatoblastoma, Liver Neoplasms, Teratoma. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Macy Easom Cancer Research Foundation, Cancer Prevention and Research Institute of Texas, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Teratoid hepatoblastoma (HB) is a rare histologic subtype of the most common pediatric liver cancer. Understanding of the clinicopathologic features and outcomes of patients with this disease is currently limited.

Methods

Multi‐institution, retrospective chart review was conducted to compare 20 children with teratoid HB to 129 children with non‐teratoid HB treated from 2004 to 2022.

Results

Of the patients with teratoid HB, 31% showed teratoid histology in pre‐treatment biopsies. All 20 patients received neoadjuvant chemotherapy, with treated tumors showing melanin (14), neuroepithelium with or without glial cells (10), squamous epithelium and whorls (9), mucinous and/or non‐mucinous glandular elements (8), primitive endoderm/yolk sac‐like areas (3), and mature and/or immature ganglion cells (3). Metastatic and relapsed lesions did not show teratoid histology in this cohort. Teratoid HB was more frequent in males (M:F 1.9:1) and children

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepatoblastomaLiver NeoplasmsTeratomaHumansMaleFemaleChild, PreschoolRetrospective StudiesInfantChildSurvival RateInfant, NewbornPrognosisAdolescentFollow-Up Studies

Stichwörter der Autor:innen

hepatoblastomaoutcometeratoid

Autor:innen und Institutionen

  • Division of Pediatric Surgery, Michael E. DeBakey Department of Surgery, Texas Children's Surgical Oncology Program and Liver Tumor Program, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA.
  • Department of Pathology, University of California San Francisco, San Francisco, California, USA.
  • Department of Pathology and Immunology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.

ORCID-Profile: Andres F Espinoza, Soo Jin Cho, Dolores H López-Terrada

Förderung

  • Macy Easom Cancer Research Foundation
  • Cancer Prevention and Research Institute of Texas
  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Hickner, B. T., Espinoza, A. F., Cho, S. J., Sarabia, S., Urbicain, M., Wang, A., Vasudevan, S. A., López-Terrada, D. H., & Patel, K. R. (2025). Teratoid Hepatoblastoma: Clinicopathologic Features and Outcomes. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31903

Vancouver

Hickner BT, Espinoza AF, Cho SJ, Sarabia S, Urbicain M, Wang A, et al. Teratoid Hepatoblastoma: Clinicopathologic Features and Outcomes. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31903

BibTeX
@article{Hickner2025,
  author = {Hickner, Brian T and Espinoza, Andres F and Cho, Soo Jin and Sarabia, Stephen and Urbicain, Martin and Wang, Ann and Vasudevan, Sanjeev A and López-Terrada, Dolores H and Patel, Kalyani R},
  title = {Teratoid Hepatoblastoma: Clinicopathologic Features and Outcomes},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31903}
}
Kostenlos starten →